Gene therapy

Cell and gene therapy concept
#Cell and gene therapy #Cell therapy #Gene therapy #RNA

What are the challenges and advancements driving CGT drug development?

In this webinar you will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and Gerard Caelles, CBO at Splice Bio. Erik Wiklund will discuss how circular RNA is crucial to the development of next-generation cell and gene therapy products. Ali Pashazadeh will explore current barriers… Read More

Webinar date:
Sponsored by Benchling and Applied StemCell
#Webinars

#Cell and gene therapy #Cell therapy #Gene therapy #RNA #Webinar

Webinar: Understand the challenges and advances driving CGTs

In this webinar on 8 October 3-4PM BST, hosted by DDW and sponsored by Benchling, you will learn about the challenges and advancements driving drug development for cell and gene therapies. You will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and… Read More

Webinar date:
Sponsored by Benchling
#News

Gene therapy
#Asklepios BioPharmaceutical #Bayer #Belief BioMed #Collaboration #Gene therapy

AskBio and Belief BioMed explore potential new gene therapies

Bayer AG and Asklepios BioPharmaceutical (AskBio) have announced a new strategic collaboration with Belief BioMed (BBM) to explore the potential for new gene therapies. Under the terms of the contract, the companies will combine efforts and experience in gene therapy technology to explore potential therapies in diseases that may be… Read More

#Business & Investment #News

#AAV #Gene therapy #Thermo Fisher Scientific #Webinar

Analysis of full and empty particles in AAV vectors for gene therapy

This advertorial appeared in DDW Volume 25 – Issue 4, Fall 2024 Read the digital issue In a recent DDW event, supported by Thermo Fisher Scientific, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, presented his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. Cryo-EM application… Read More

#Exclusive Content

#Cell and gene therapy #Cell therapy #Gene therapy #RNA

Webinar: Learn about the challenges for cell and gene therapies

In this webinar on 8 October 3-4PM BST, hosted by DDW and sponsored by Benchling, you will learn about the challenges and advancements driving drug development for cell and gene therapies. You will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and… Read More

Webinar date:
Sponsored by Benchling
#News

#Cell and gene therapy #Cell therapy #Gene therapy #RNA

Webinar on the advancements driving cell and gene therapies

In this webinar on 8 October 3-4PM BST, hosted by DDW and sponsored by Benchling, you will learn about the challenges and advancements driving drug development for cell and gene therapies. You will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and… Read More

Webinar date:
Sponsored by Benchling
#News

Cell and gene therapy concept
#Cell and gene therapy #Cell therapy #Gene therapy #RNA

What are the advancements driving CGT drug development?

In this webinar on 8 October 3-4PM BST, hosted by DDW and sponsored by Benchling, you will learn about the challenges and advancements driving drug development for cell and gene therapies. You will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and… Read More

Webinar date:
Sponsored by Benchling
#News

Human eye
#Gene therapy #Genetics / genomics #Ophthalmology #Rare disease #University of Florida

Gene therapy restores vision in first-of-its-kind trial

A gene therapy developed by University of Florida scientists restored useful vision to most patients with rare condition Leber congenital amaurosis type I (LCA1) in a small trial. Patients who received the highest dose of the gene therapy saw up to a 10,000-fold improvement in their… Read More

#News #Trending News

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

This week: Discover innovative approaches in AAV vector analysis

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

Gene therapy concept
#Cell and gene therapy #Cell manufacturing #Cell therapy #Gene therapy

Looking ahead for cell and gene therapy

DDW’s Megan Thomas discusses the future of the cell and gene therapy (CGT) sector with industry experts, who predict what to expect in 2024 and beyond. Emphasis on manufacturing  Experts were unanimous in their view of how far the cell & gene therapy (CGT) sector has come and the milestones… Read More

#Exclusive Content

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

Register now: AAV characterisation using cryo-EM and deep learning

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

Collagen and vitamin drop skin cell
#Ageing #Cell and gene therapy #Gene therapy #Rejuvenation therapies

Using gene therapy to live longer, healthier lives

Sharon Rosenzweig-Lipson, PhD, is Chief Scientific Officer of Life Biosciences. She discusses with DDW’s Megan Thomas the company’s lead programme; a gene therapy called ER-100. Prolonging health span with drug development Life Biosciences aims to restore and prolong a patient’s health span by targeting the underlying biology of ageing and… Read More

#Exclusive Content

Gene therapy for haemophilia
#CSL #Gene therapy #Haemophilia #Scottish Medicines Consortium (SMC)

First gene therapy for haemophilia B accepted in Scotland

The Scottish Medicines Consortium (SMC) has accepted CSL Behring’s Hemgenix (etranacogene dezaparvovec) for use within NHS Scotland on an interim basis, until full marketing authorisation is granted. The single infusion gene therapy is recommended for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors. The… Read More

#News #Regulatory

Cell and gene therapy concept
#AAV #Cell and gene therapy #Gene delivery #Gene therapy #Viral vectors

Improving viral vector safety for gene therapies

Dr Andrea O'Hara, Senior Product Manager at Azenta Life Sciences asks why integration site analysis (ISA) is critical for the safety and efficacy of viral vectors for gene therapy. Cell and gene therapies have revolutionised how clinicians treat a variety of diseases including cancer, blindness, and metabolic disorders. With these… Read More

#Exclusive Content

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

Webinar: Discover AAV characterisation using cryo-EM

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

#Cell and gene therapy #Cell therapy #Gene therapy

Reflecting on the past and present of CGT development

DDW Multimedia Editor Megan Thomas speaks to industry experts to reflect on where the industry and has come over the last year, gain an understanding of what to expect from the 2024 cell & gene therapy (CGT) sector, and where future opportunities may lie. Workforce development and training Bruce Levine,… Read More

#Exclusive Content